sales in China
“10-K Item 1A: 'sales in China constituted approximately 27% of our revenues in fiscal 2026'”
Updated
The most significant concentration Cabot discloses is sales in China at 27%, classified MEDIUM by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Source: Cabot’s SEC Form 10-K filed — view the filing on SEC EDGAR ↗
Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).
“10-K Item 1A: 'sales in China constituted approximately 27% of our revenues in fiscal 2026'”
“10-K Item 1: 'Sales to five major tire customers represent a material portion of Reinforcement Materials’ total net sales and operating revenues.'”
Cabot's disclosed concentrations are one geographic and one customer-based exposure, both medium-share. Sales in China constituted approximately 27% of revenues in fiscal 2026. That is a structural exposure: it ties results to Chinese demand, trade policy and currency conditions rather than to any single counterparty. Separately, sales to five major tire customers represent a material portion of Reinforcement Materials' total net sales and operating revenues. The filing gives no percentage for this one, so its precise weight cannot be quantified from the source, but its character is a dependency on a handful of buyers. The two exposures are likely related, since tire demand is a significant channel for the China business, though the filing does not say so and the overlap should not be assumed. Of the pair, the tire-customer dependency is the more idiosyncratic: a purchasing decision, contract renegotiation or loss at one of those customers could affect segment results directly. The China share is the more macro-driven. Together they are the items most likely to move the verdict.
For the engine’s reasoning on CBT’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.
| Symbol | Name | HIGH | MEDIUM | LOW | Total |
|---|---|---|---|---|---|
| ALB | Albemarle Corporation | 1 | 1 | 0 | 2 |
| APD | Air Products and Chemicals, Inc | 1 | 1 | 0 | 2 |
| ASPN | Aspen Aerogels, Inc. | 1 | 0 | 0 | 1 |
| AVNT | Avient Corporation | 1 | 0 | 0 | 1 |
| CBT● | Cabot Corporation | 0 | 2 | 0 | 2 |
| ASH | Ashland Inc. | 0 | 0 | 0 | 0 |
Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.